Moderna, Inc. (MRNA) – COVID vaccine sales to increase through booster shot

Moderna is working on other vaccines that target HIV, the flu, respiratory syncytial virus and cytomegalovirus. It’s also testing cancer drugs and recently inked a deal with privately held Carisma Therapeutics.

Highlights

Valuation

– Enterprise Value
– CrispIdea Forecast
– P/E Analysis
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum

Actual & Historical Performance

– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Segment Performance
– Key Developments

Peer Performance

– Summary
– Profitability
– Growth
– Price Performance

Ownership

Stock Price Performance

Crispidea Coverage

No of Pages : 31